This inventor holds 1 USPTO granted patent. Top assignees: Indiana University, University of Illinois. Active years: 2023.
Company Filing History:
1 out of 804 
1 out of 2,420 
Years Active: 2023
Title: Najing Su: Innovator in Pharmaceutical Research
Introduction
Najing Su is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that can inhibit nicotinamide phosphoribosyltransferase (NAMPT). His work has implications for treating diseases such as pulmonary arterial hypertension (PAH).
Latest Patents
Najing Su holds 1 patent for his invention titled "Nicotinamide phosphoribosyltransferase inhibitors and methods for use of the same." This patent discloses compounds that act as inhibitors of NAMPT, along with methods for their use in treating or preventing various diseases. The compounds described include those of Formula (II) and their pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Najing Su has worked at prestigious institutions such as Indiana University and the University of Illinois. His research has focused on innovative approaches to drug development, particularly in the area of metabolic diseases.
Collaborations
Najing has collaborated with notable colleagues, including Tom G Driver and Wrickban Mazumdar. These collaborations have furthered his research and contributed to advancements in the field.
Conclusion
Najing Su's work in pharmaceutical research exemplifies the impact of innovative thinking in addressing complex health issues. His contributions continue to influence the development of new therapeutic strategies.